Leaflet SPIRIVA RESPIMAT 2.5mcg inhalation solution
Indicated for: asthma; chronic obstructive pulmonary disease
Substance: tiotropium (antimuscarinic bronchodilator)
ATC: R03BB04 (Respiratory system | Other drugs for obstructive airway diseases, inhalants | Anticholinergics)
Tiotropium is a bronchodilator used for the treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It works by blocking muscarinic receptors in the airways, relaxing the muscles and making breathing easier.
The medication is administered via inhaler, usually once daily, as directed by a doctor. It is used for long-term control of symptoms and not for quick relief of breathing crises.
Patients should strictly follow the instructions for using the inhaler and inform their doctor of any unusual symptoms. It is important not to exceed the recommended dose.
Side effects may include dry mouth, cough, throat irritation, and, in rare cases, severe allergic reactions or breathing difficulties. Patients should be informed of these risks before starting treatment.
General data about SPIRIVA RESPIMAT 2.5mcg
- Substance: tiotropium
- Date of last drug list: 01-05-2026
- Commercial code: W58575005
- Concentration: 2.5mcg
- Pharmaceutical form: inhalation solution
- Quantity: 1
- Product type: original
- Price: 137.78 RON
- Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).
Pharmaceutical forms available for tiotropium
Concentrations available for tiotropium
- 10mcg
- 18mcg
- 2.5mcg